Inbox Robot - Choose newsletter content

Choose content

Enter keywords to create a newsletter

Create account

Enter your registration information

Set preferences

Set up your newsletter name, delivery and time zone preferences

Hint: Enter different keywords to generate new results.

Now you can:

Search the news index.
Browse more than 1 million newsletters by category.
Use preset newsletters:
- PARP inhibitor

PARP inhibitor Newsletter

PARP Inhibitor Biomarkers Market Expands at 8.5% CAGR Through 2032 | Persistence Market Research 05 Feb 2026 16:00 GMT
… Challenges 1. PARP Inhibitor Resistance Resistance to PARP inhibitors can develop … Indications New clinical applications for PARP inhibitors, including trials for … for the PARP inhibitor Lynparza®. Conclusion The PARP inhibitor biomarkers …
Repression of PRMT activities sensitize human homologous recombination-proficient ovarian and breast cancer cells to PARP inhibitor treatment 03 Feb 2026 22:51 GMT
… for the PRMT and PARP inhibitor combination may be … many genes potentially involved in PARP inhibitor sensitivity (i.e … the enhanced cellular sensitivity to PARP inhibitors. Finally, tumor … HR-proficient tumors to PARP inhibitors by repressing transcription …
IMUNON SHARPENS FOCUS ON ITS PROMISING PIVOTAL PHASE 3 OVARIAN CANCER STUDY 05 Feb 2026 13:05 GMT
… of poly ADP-ribose polymerase (PARP) inhibitors as part of maintenance …
Eikon, Veradermics close IPOs, as Salspera joins queue 05 Feb 2026 11:21 GMT
… , and Eikon also has two PARP inhibitors in early-stage testing …
Eikon Therapeutics nets a $381M IPO amid burst of biotech offerings 05 Feb 2026 03:39 GMT
… testing are a pair of “PARP” inhibitors that are supposed to …
Cutting-Edge Discoveries from MSK Research – February 4, 2026 05 Feb 2026 01:53 GMT
… it may predict responsiveness to PARP inhibitors and other DNA repair …
<![CDATA[Beyond Chemo: Dr Ana Garrido-Castro on the Evolving TNBC Landscape]]> 04 Feb 2026 21:31 GMT
… a complex map of immunotherapy, PARP inhibitors, and a rapidly expanding …
Ambry’s Contributions to MAVEs Support Thousands of Patient Reclassifications and Expand to New Genes 04 Feb 2026 16:56 GMT
… functionally abnormal (6%) based on PARP inhibitor sensitivity, a measure of …
Chasing cost: Cancer care toxicity and the hope from Biosimilars 04 Feb 2026 04:15 GMT
… , the introduction of generics for PARP inhibitors such as rucaparib and … inhibitor; CHA= Cytostatic Hormone antagonist; PARP= Poly (ADP-ribose) Polymerase inhibitor …
Allarity Therapeutics announces that its collaborative Phase 2 trial with the United States Veteran’s Administration Combining Stenoparib with Temozolomide in Relapsed Small Cell Lung Cancer is Now Open for Enrollment 03 Feb 2026 13:00 GMT
… studies have shown that PARP inhibitors can enhance the … temozolomide with first generation PARP inhibitors is very active … numerous cancers. By inhibiting PARP and blocking WNT pathway activation … of stenoparib, a novel PARP/tankyrase inhibitor for …

Satisfied with the content?

Continue to create your account.

Choose content

Create account

Set preferences

EIN MARKETING SOLUTIONS

EIN NEWS SERVICES

ALL NEWS PUBLICATIONS